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The Physiology of Reproduction –
Quo vadis?
Richard Ivell* and Ravinder Anand-Ivell
School of Biosciences, University of Nottingham, Nottingham, United Kingdom
The reproductive system in males and females reflects a highly dynamic underlying
physiology. Yet our current understanding of this system is still largely based
upon relatively simplistic snapshots of individual component cells and tissues.
Gamete production as well as gonadal hormone synthesis and its influence are the
manifestations of dynamic and redundant informational networks and processes, whose
qualitative and quantitative dimensions, especially through development from embryo
through puberty and adulthood into ageing, are still largely uncharted. Whilst the recent
huge advances in molecular science have helped to describe the components of the
reproductive system in ever greater detail, how these interact and function in space
and time dimensions is still largely obscure. Recent developments in microfluidics, stem
cell biology, and the integration of single-cell transcriptomics with tissue dynamics are
offering possible methodological solutions to this issue. Such knowledge is essential
if we are to understand not only the normal healthy functioning of this system, but
also how and why it is affected in disease or by external impacts such as those from
environmental endocrine disruptors, or in ageing. Moreover, operating within a complex
network of other physiological systems, its integrational capacity is much more than the
generation of male and female gametes and their roles in fertility and infertility; rather,
it represents the underpinning support for health and well-being across the lifespan,
through pregnancy, puberty, and adulthood, into old age.
Keywords: hormonal networks, parameter variance, pulsatility, endocrine disruptors, uterine peristalsis, systems
biology
INTRODUCTION
Physiology has been defined as the “science of health” as well as the “science of life.” For reproductive
physiology, this is not unproblematic since much of what we consider as reproduction is not
essential to either. At an individual level, disorders of the reproductive system such as infertility are
generally not life-threatening, nor lead to major bodily dysfunction. Whilst some might consider
that infertility is not a disease, at the population level, any disruption of reproductive function can
lead to loss of a population or even a species. And at the individual level, such malfunction can
lead to considerable personal grief. Accordingly, in the competitive jungle of research funding,
reproduction does not compete well with cancer, diabetes, or neurodegenerative illness, even
though fertility problems may impact a larger number of people, especially as child-bearing is
being delayed until the mid to late 30s or beyond. Our field is further disadvantaged by a minimal
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engagement from the pharmaceutical industry, for whom the
reproductive sector is a litigious minefield because of the subtle
risks associated with exposures of an unborn child. Consequently,
most drugs used today still have their roots in substances
discovered many decades ago, and which if invented today would
probably find it difficult and expensive to receive approval.
Finally, the relative success of Assisted Reproductive Technology
(ART) has lulled society into thinking that infertility issues are
largely resolved.
A consequence of such attitudes is that research into
fundamental reproductive physiology has not progressed
as much as in other fields and owes its advances often to
translation from different sectors of physiology. Moreover,
when we assess the articles being submitted to our specialist
Frontiers section on “Reproduction,” by far the majority
represent incremental improvements to existing clinical
procedures and applications, and relatively few contributions to
innovative basic science.
In this essay, we should like to draw attention to why
Reproductive Physiology merits more fundamental research – in
particular, into those aspects which differ from other areas of
Physiology. This is intended neither as a comprehensive review
of recent breakthroughs and successes, nor as a detailed list of
future research targets. Rather, we want to raise ideas to stimulate
innovative approaches to understanding the field as well as its
applications into a broad array of translational targets.
THE DYNAMIC PHYSIOLOGY
Most areas of physiology are governed by a relatively static
image of an adult system, whose rules and boundaries are
controlled by homeostasis. There is a normal (healthy) state
where components have fixed relationships to one another,
which may become altered in a disease condition. In contrast,
the reproductive system is never static. In the adult female,
reproductive status is ruled by the dynamic depletion of the
follicle reserve, from birth to old age, superimposed upon which
is the menstrual cycle, or its equivalent, regulating not only
the final preparation of the egg for fertilisation and eventual
pregnancy, but also the organs of the reproductive system such
as the uterus and mammary glands, as well as other systems
in the body such as the bone and skeletal system, the osmotic
balance, the immune system, and especially the brain and
behaviour. In the male, there may be no monthly cyclicity, nor
limited gamete reserve, but the system is still very dynamic,
with continued spermatogenesis from stem cells throughout
adult life. With the possible exceptions of intestinal epithelial
sloughing and haematopoiesis, no other organ system is adapted
to producing continually many millions of cells a day whose
function is external to the organism, and which must be capable
of generating perfectly functional individual cells (spermatozoa)
for many decades.
The parameters governing both male and female reproductive
systems – even in the adult – are therefore never static, but
to be seen always as snapshots of very dynamic processes,
the dimensions of which can at best only be approximated,
much as a photograph can never display the living reality
of the subjects.
However, the reproductive system also reciprocally
dictates the health of the organism, not only in adulthood,
but especially during prenatal development, puberty, and
in senescence, adding further dimensions to the dynamic
interplay of the cells and organs involved. Events occurring
early in development can have big effects at later stages,
as in the DOHaD (Developmental Origins of Health and
Disease) concept. It is our lack of understanding of the
dynamic processes involved and their regulation which may
account for the fact that many of the commonest diseases
affecting us are those involving the reproductive system
and its dynamic development (polycystic ovarian syndrome,
endometriosis, fibroids, premature ovarian insufficiency, male
and female infertility, breast, endometrial, and ovarian cancers,
benign prostatic hyperplasia, testis and prostate cancers, and
hypoandrogenemia).
An aspect of this, which is not often appreciated, is the
large variation in clinical and biological parameters in the
human population associated with reproduction, which we
consider “normal” and non-pathological. Part of this may
reflect the point raised above that, since disruption of the
reproductive system is rarely life-threatening, we are more
tolerant of variation per se. For the male, for example, the
WHO latest acceptable reference range for sperm concentration
is 15–259 million per ml with progressive motility of 32–75%
and for normal morphology is only > 4% (Cooper et al.,
2010; WHO, 2010)! We have shown that the normal range
for circulating insulin-like peptide 3 (INSL3), a measure of
Leydig cell functional capacity (i.e., total number of Leydig
cells in the testes compounded with their differentiation status)
is 0.39–1.87 ng/mL (5%, 95% confidence intervals) in healthy
young men (Anand-Ivell et al., 2021). This is a large variation,
compared to other, comparable non-episodic health parameters,
such as thyroxine (5.5–12.5 µg/dL) or haemoglobin (14.0–
17.5 g/dL). For women, there is a similar large range for the
age at natural menopause (40–58 years) or circulating AMH
(6.4–67.9 pmol/L in reproductive age women), both a reflection
of egg reserve. It is important to note that these are quasi-
constitutive parameters not subject to acute feedback control,
for example, by the hormones of the hypothalamo-pituitary-
gonadal (HPG) axis. Yet we understand very little about the
causative factors involved in this large variation in reproductive
parameters, except that they probably reflect events early in
development either before birth or during puberty. Nor do we
fully understand the roles played by ethnicity and genetics in
establishing these normal ranges.
Such reproductive parameters probably depend upon stem cell
proliferation and differentiation, the important features being
the relative timing of these two processes and how that timing
is controlled. There are similarly dynamic mechanisms affecting
cell death (apoptosis) in these lineages. Thus, reproductive
physiology must be seen as a complex interaction between
multiple highly dynamic processes. Yet most of our knowledge
and understanding is based upon sporadic snapshots of mostly
adult scenarios.
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A further exacerbating factor is that we know most about
very few species, such as the human or the mouse, and then
try to extrapolate and adapt this knowledge to other animals.
Whilst this may be reasonable for some species, such as
ruminants, or primates, it can become problematic for exotic
and endangered species, or lower vertebrates, whose physiology
is often nebulous at best. There is therefore a need for elaborating
more and alternative animal models to help delineate these
complex processes.
INFORMATION THEORY 101
Information theory, originally derived from telecommunication
to describe information transfer and its efficiency, is highly
pertinent to any understanding of how living systems work,
yet has surprisingly found little mention in basic biology texts.
The flow of information – its production and its reception –
is the key difference between living and non-living, between
life and death, and between health and disease (Yockey, 1992).
Because the reproductive system is, by definition, very ancient
and essential for the survival of the species, we see a wide
range of informational systems being used, both paracrine
and endocrine. The HPG axis represents a classic example for
information transfer at a distance. Not only are the gonadotropin
hormones that are produced by the pituitary gland, complex
information carriers whereby multiple peptide and carbohydrate
epitopes within the same molecule all need to be correctly “seen”
by their cognate receptors, thus minimising misinformation,
but the system additionally employs both pulsatility (digital
encoding) and negative feedback to ensure correct and adequate
information transfer.
Both gonadal steroids and certain peptide hormones (e.g.,
inhibin B) feed back to the hypothalamus and pituitary to
regulate the output signal. Whilst we now understand much
of the qualitative and anatomical detail, surprisingly, we know
only very little about the quantitative aspects involved here.
How do those cells receiving the feedback quantitatively measure
the amounts of gonadal steroids, inhibin B, or perhaps other
molecules feeding back information; how are these feedback
signals quantitatively integrated to generate not just a yes/no
secretion response but an appropriate quantity of a particular
hormone by the hypothalamus and/or pituitary? Regarding
pulsatility, we still know very little about the detailed mechanisms
involved. It is 40 years since the pioneering study by Wildt et al.
(1981) which showed for macaques that GnRH pulse frequency
determined the quantities of gonadotropins released and whether
preferentially FSH or LH or both. Although Johannes Veldhuis
and colleagues have elaborated examples of the changes that
occur in gonadotropin pulsatility with development, sickness,
or ageing (e.g., Veldhuis et al., 1994; Liu et al., 2005), little of
this knowledge has yet been practically translated into clinical
application. We still rely upon single measurements of peripheral
hormones, hopefully at a similar time of day, or at best a GnRH
challenge test. There is obviously a major technical obstacle
here: how can we measure and interpret pulsatility in a routine
clinical context? Only few studies have tried to approach this
issue (e.g., Henley et al., 2009; Liang et al., 2019; Poudineh
et al., 2020). Given our advances in other areas of technology,
it is surprising that we seem to be no nearer to harnessing the
informational content in pulsatility, especially when we consider
how many different hormone systems appear to make use of
it and how important it might be for the understanding of
health and disease. We could learn from findings from other
pulsatile hormones, such as parathyroid hormone, where loss
of appropriate pulsatility (rather than its concentration) is a
biomarker of osteoporosis (Chiavistelli et al., 2015). Conversely,
administration of hormones or drugs in a pulsatile fashion is
still very limited. Rather, hormones, such as GnRH analogues,
may be administered as a single, high-concentration bolus
specifically and chronically to desensitise and hence inactivate
their receptors and the relevant feedback loop. Even for oxytocin,
another well-characterised pulsatile hormone, it is still advocated
at labour to deliver it as a continuous rather than a pulsed
infusion (e.g., Tribe et al., 2012); even though it requires
higher amounts of the hormone and can lead to oxytocin
receptor desensitisation, including possibly within the foetal
brain and leading to a risk of autism (e.g., Weisman et al.,
2015). A greater understanding of how hormones are encoded
and decoded in pulsatile systems could open up many new
opportunities for drug-based therapies, besides expanding our
understanding of disease.
NETWORKS, NOISE, AND VARIANCE
Historically, the great successes achieved in combatting disease
with single drug replacement strategies, such as the application
of insulin in diabetes, or thyroxine in hypothyroidism, have
created a dogma that most physiological systems can be similarly
“fixed” by activation of a simple pathway; conversely, that
if a gene product is important, its knockout or removal
must show a clear phenotype. The reality that is especially
being highlighted by the “big data” approaches of GWAS
studies, or global NGS-sequencing, is that many genes may
be involved in a particular phenotypic pathway, none of
which individually may deserve the appellation of being
“causal” or “essential.” Rather genes and their products are
linked together into complex and dynamic networks whose
functionality can tolerate a degree of redundancy, but which are
nevertheless holistically essential for the appropriate function of
a cell or tissue.
A good example is provided by the dialogue between the
blastocyst and the endometrial lining of the uterus at the
time of implantation. We now understand that mutual and
multiple signals from both the blastocyst as well as from
the receptive endometrium interact in a largely temporally
sequential fashion, subsequent steps being “mostly” dependent
on successful “hand-shaking” of preceding steps. The term
“mostly” is highlighted because this system allows a modest
redundancy, both in molecular and in temporal terms. Only
when the negotiation is satisfactorily finalised can the blastocyst
be considered as implanted and placentation can proceed. The
negotiation involves quality checks: on the embryo to determine
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whether it has the potential to develop into a healthy offspring
and on the mother to test whether she will be able to take
this baby to term. If the quality checks fail, then there is
miscarriage, preferring to reserve energy for a new pregnancy
rather than risking failure at a later stage (e.g., Macklon and
Brosens, 2014; Valdes et al., 2017; Craciunas et al., 2019;
Ewington et al., 2019).
In such a system, it is difficult to identify single key molecules
or biomarkers essential to successful early pregnancy; in general,
the dynamics of the negotiation process are very hard to measure.
This is even more difficult in species where the apposition
time of the embryo to the uterine lining is much longer than
in the human. In analogy to the “quiet embryo” hypothesis
(Baumann et al., 2007), it is likely that when the negotiation
is rapid and signalling within this network is relatively quiet,
it is a sign of a healthy implantation process; in contrast
when it is protracted or “noisy” with much information flow,
this could be an indication that the process is problematic
with a high risk of failure. But how can we assess such a
dynamic process? Importantly, how can we manipulate this
process, and should we? By overriding this quality control
dialogue, there is a risk that we might be retaining an
offspring which otherwise might have been subject to natural
selection. But what if the quality control process itself is faulty?
One consequence of this hypothesis might be that molecular
parameters will show a higher level of “noise,” or variance, with
a problem outcome, though may not show alterations in mean
parameter levels.
Consider, for example, the situation during ART when
multiple healthy-looking embryos are transferred and only one
succeeds to implant. Was the decision here a quantitative one, or
qualitative, or a dynamic combination of these?
A related example concerns the extent to which informational
processes may involve stochastic mechanisms. During the
early cell divisions of the fertilised egg, the resulting morula
comprises more-or-less identical blastomeres, each of which
can, if separated, give rise to an independent individual. Early
blastomeres are totipotent. There are few geographical clues until
the blastocyst stage, except for those resulting from the point
of sperm entry, and any unequal distribution of the original
egg cytoplasm and its contained gene products. Only later,
with the formation of the blastocoel, inner and outer layers,
and the initial trophoblast, can clear polarity be established,
and cell lineages become determined. However, attempts to use
individual blastomeres as diagnostic tools to deliver prognosis on
the resulting embryo have generally not succeeded, largely due
to the very heterogeneous nature of blastomere gene expression
profiles. One explanation for this could be that initially gene
expression in the early morula is mostly a stochastic process
rather than being deterministic. The blastomere genomes are
mostly not epigenetically determined once the zygote is formed
and will anyway undergo an erasure phase in the blastocyst.
The stochastic activation of genes would have two consequences:
first, it could establish a random informational (chaos) network
which could then progressively by feedback fixate upon certain
pathways and relationships and second, it could provide an active
mechanism for proof-reading the genome. Both mechanisms
would have definite advantages for the survival of the offspring.
From a pragmatic perspective, such a stochastic mechanism
would also explain why there may be an upper limit to the
success rate of in vitro fertilisation (IVF), since any such
proof-reading step implies the necessary loss of inadequate
zygotes. But such a mechanism would also explain why IVF
succeeded in the first place, since it would intrinsically be
able to rectify any potential damage caused by the unusual
IVF environment. It will be very interesting to find a way to
test such a paradigm and the resulting informational networks
and thus redefine the impact of in vivo and in vitro culture




The relatively recent relaxation of socio-political boundaries has
introduced the concept of gender fluidity. Until only a few years
ago, scientists were seeking and finding molecular mechanisms
which by mutual inhibition would ensure the polarity of the sexes
and thus the prerequisite for reproduction and the continuation
of the species. Classic examples of this are the expression of
the SRY gene on the Y chromosome (Koopman et al., 1990), or
the reciprocal inhibition of FGF9 and Wnt4 (Kim and Capel,
2006) during early gonad development. The demonstration of
such examples unconsciously suggests that subsequent unclear
sex is likely due to aberrations of development, with research
then focussed on singular defects of an otherwise perfect system.
However, we now realise that gender physiology is not as
polarised as we once imagined; it appears more plastic, whereby
dynamic and complex informational networks, as discussed
above, can be influenced in more than one direction. This would
allow a degree of redundancy in the system and a possible
blurring of the boundaries.
To illustrate the issue let us consider the foetal gonadal
hormones. We are used to considering that phenotypic
androgenisation is brought about by testosterone produced by
the foetal testes within the so-called “masculinisation window”
(Welsh et al., 2014). Less well known is the fact that female
foetuses produce almost half the concentration of testosterone as
male foetuses (Ivell et al., 2017), mostly from the foetal adrenal
gland, and certainly more than sufficient to influence androgen-
sensitive systems. Not only that, but in multiparous species such
as rodents or pigs, gonadal hormones like testosterone or the
peptide INSL3 can transfer between male and female foetuses in
utero (Vernunft et al., 2016), without having any apparent effect
on the female phenotype. It is argued that in the female foetus,
the receptors for these hormones are suppressed and therefore
unresponsive, but then we need to ask why the androgen
receptor in mammals has been evolutionarily segregated to
the X chromosome, where there is a greater likelihood of it
being expressed in females or recessively mutated in males.
Could the solution be that whilst we know a lot about the
qualitative response of cells to hormones, we still know very
little about the quantitative response: how much hormone is
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sufficient to elicit an appropriate response in vivo? Evidently,
we still understand far too little about the qualitative and
quantitative complexity of the informational networks governing
the phenotypic expression of gender.
We also need to consider why the reproductive system
has conserved the components of the HPG axis across the
whole of chordate evolution, and yet when it comes to sex
determination appears to employ a wide diversity of genetic
systems in mammals, birds, and reptiles. For a physiological
system which is absolutely essential for the survival of the species,
this is indeed surprising, and suggests that there is much that we
still do not comprehend.
ENDOCRINE DISRUPTORS
Reduced reproductive performance was one of the first
physiological systems to be recognised as being negatively
influenced by endocrine disrupting chemicals (EDCs) in the
environment (Gore et al., 2015). These pervasive manmade
substances (pesticides, plasticisers, fire retardants, microplastics,
etc.) are now known to influence most organ systems of
the body, often at very low exposures and concentrations,
and ambient levels are increasing. Importantly, they appear
not to conform to conventional toxicological paradigms, but
can show non-monotonic dose–responsiveness even down
to very low concentration. Moreover, because of epigenetic
changes, they may also impact later life periods and subsequent
generations. Among their key characteristics (La Merrill et al.,
2020), they appear to function by interfering with diverse
endocrine components (hormones, receptors, transporters,
enzymes, etc.). However, in the light of what has been
discussed earlier, they may function additionally by subtly
modulating informational networks. One consequence of this
is that effects may be due less to absolute changes in
endocrine parameters and more to increased noise or variance
in such informational systems. Such an effect was suggested
in assessing the effect of phthalate exposure on the risk
of cryptorchidism or hypospadias in male human foetuses
(Anand-Ivell et al., 2018).
The biggest problem to be faced with regard to EDCs is that
they often appear to be insensitive to conventional regulation
applying toxicological paradigms. Regulatory agencies require
more and novel approaches if they are to be able to keep up
with the many millions of tons of such substances released into
the environment every year. While some in vitro or in silico
methods are showing considerable promise, these work only
by assuming that EDCs are mimicking natural hormones and
their interactions with receptors. Yet, as we have shown above,
EDCs appear to illustrate a range of diverse endocrine properties,
and moreover may function within the context of dynamic and
redundant networks, so that such relatively simplistic approaches
may fail to recognise a majority of potential EDC compounds.
A further complication in the interaction between EDCs
and reproductive physiology is that we now recognise that
also many pharmaceutical compounds are behaving similarly.
Initially, it was discovered that the contraceptive component
ethinyl oestradiol was entering natural water systems relatively
unscathed and having potent effects to feminise male fish (Jobling
et al., 2006). Therefore, precisely those properties which make a
pharmaceutical resistant to degradation in the body are also those
that allow it to persist in the environment once excreted (Heberer,
2002). Thus, our marine and freshwater environments are having
to cope with increasing amounts of common pharmaceuticals,
including contraceptive agents, analgesics, hypertensive drugs,
etc. Their impact on food chains is still largely uncharted.
Also of concern is that we are discovering that many
pharmaceuticals, previously considered relatively harmless, are
now seen as impacting on foetal development. The analgesics,
paracetamol (acetaminophen) and ibuprofen, have been shown
in animal models as well as in human epidemiological studies to
affect the development of the foetal gonads following exposures
during pregnancy (Kristensen et al., 2016; Kilcoyne and Mitchell,
2019). The issue here is that previous regulatory strictures
regarding testing evidently did not take account of the subtle
mode of action of EDCs, particularly on the reproductive system
or during pregnancy. Research is still at a very early stage
here, and it is likely that the future will reveal that several
common or over-the-counter pharmaceuticals may be found
to have EDC-like effects. Particularly concerning in this regard
is also the massively increased prescription of psychoactive
drugs, such as SSRIs, to women of reproductive age, and to
adolescents going through puberty (Fenger-Grøn et al., 2011;
Grzeskowiak et al., 2012). These are categories which we know
are likely to be very sensitive to the effects of potential endocrine-
acting compounds.
AGE AND REPRODUCTION
It is the purpose of any species, once it has reached sexual
maturity, to reproduce and secure the continuation of the gene
pool. Humans are different. The attainment of sexual maturity
at the end of puberty is separated by several years both from
parenthood itself, as well as from the behavioural maturation that
is required for a successful family. There are three sequelae to
this. First, women experience a succession of futile physiological
preparations for pregnancy without ever becoming pregnant.
Evolution has not prepared women for this. Every month cyclic
hormones activate stem cells to begin preparing the endometrium
or breast tissue for an eventual pregnancy without this event
actually occurring, and a default programme is then invoked
to reset the calendar. Besides the accompanying menstruation
and/or mental disruption this provokes, it has been also suggested
that this activation/reset system is one factor predisposing
women to reproductive tissue cancer (Olsson and Olsson, 2020).
Second, contraceptive systems have been developed to provide
planning for reproduction to coincide with an optimal economic
environment. The commonest contraceptives for women still
rely on manipulating the cyclic hormones following a paradigm
which is now more than 60 years old. Whilst choice and
alternatives also for men are needed, few new concepts have
found acceptance. Third, socio-economic pressures have pushed
the age at which families are started into the mid-30s or
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older. Fertility in women declines rapidly from the early 20s
onwards, with mean TTP (time-to-pregnancy with unprotected
intercourse) shifting from about 3 months at age 20–25, to
6 months or longer at 30–35 years, and >24 months by the
age of 41. Whilst modern ART procedures have done much to
alleviate such infertility issues, and even the freezing of youthful
ovarian tissue or oocytes has progressed to mainstream, there
are inevitably consequences of such alterations of biology for
which evolution has not prepared us. Maternal and paternal age
is known to be not only associated with increased genetic risk for
the offspring, but also subtle epigenetic effects which may only
become apparent later in life (Aiken and Ozanne, 2014; Preston
et al., 2018).
There is still much we do not understand about the
physiological impacts of this shift in family planning. But
increased life expectancy has also thrown emphasis on the
endocrine roles played by the gonads in older age. The gonads
and reproductive system not only serve the production of
offspring, but their hormones contribute majorly to health
and overall well-being. The exhaustion of the ovarian follicle
reserve in women at mean age 51 years signals the menopause,
though this is not an abrupt transition but may progress
over several years as the resident follicles slowly lose their
capacity to produce hormones. Until recently, loss of follicles was
considered synonymous with loss of the sex steroids oestradiol
and progesterone, and to date hormone replacement therapy
(HRT) has focussed only on these two molecules. However, it is
becoming clear that the follicles also produce other hormones,
such as the gonadal peptides INSL3 or relaxin, which are also
lost to the circulation at the menopause. Recent studies in
mice and humans have shown that loss of INSL3 expression
or of its specific receptor leads to osteopenia or osteoporosis
(Ferlin et al., 2008), and relaxin has markedly positive effects
on cardiovascular physiology and fibrosis (Leo et al., 2019),
indicating that future HRT concepts might need to consider
replacing additional hormones.
In men, similarly, the gonads also produce peptide hormones,
such as INSL3, in addition to steroids like testosterone.
Importantly, these also decline significantly with increasing
age. Whereas testosterone declines at between 5 and 7% per
decade, INSL3 declines at almost 15% per decade, since the
latter, being quasi-constitutive, is not acutely compensated by
increasing gonadotropins (Anand-Ivell et al., 2006) and is a true
reflection of the age-dependent decline in Leydig cell functional
capacity. Besides a possible role for INSL3 in osteoporosis in
men, this decline in Leydig cell function adds to the growing
debate about whether or not to supplement older men with
testosterone. At present, HRT for men is mostly restricted to
those exhibiting specific late-onset hypoandrogenemia (LOH),
which affects only about 2% of elderly men and is characterised
by specific androgen-deficiency symptoms (Basaria, 2013; Pye
et al., 2014). Further research is evidently required to explore
this age-dependent endocrine decline in men which accompanies
increased frailty, cognitive decline, and increased incidence of
metabolic syndrome. A new kind of HRT concept for men, with
broad application, could go a long way to alleviating many of the
debilitating ailments affecting men as they get older. In both men
and women, the gonads are not just meant to produce gametes,
but contribute to overall well-being and general health.
BIG DATA
Recent years have witnessed a revolution in our ability to gain
information about genes and their expression, with technologies
such as GWAS analysis, MS-proteomics, NGS RNA-sequencing,
as well as microarrays, allowing for the first time a global
and comprehensive approach to measuring molecular events
in cells, tissues, and organisms. In turn, this has led to many
new statistical methods to distil out key events and pathways
from these large datasets. Whilst no doubt providing much new
information about physiology, these approaches still only achieve
a molecular snapshot of what is going on. As alluded to the above,
part of the difficulty is that we are still treating the objects of our
study using simplistic paradigms and hypotheses, which ignore
the dynamic nature, the complexity, and the redundancy, of what
is driving physiology, particularly in reproductive tissues and
organs. Many recent “big data” studies have not succeeded in, for
example, identifying key biomarker(s) for healthy endometrium,
or healthy follicles, or fertile sperm. Rather they illustrate
redundancy, or place a probability on a pathway, with few if
any studies coming up with equivalent and comparable results
for a particular target. The problem is not the methodology,
but the over-simplistic hypotheses that we apply. Evolution has
had many millions of years to perfect informational systems
which are robust, redundant, highly dynamic, and flexible. Such
systems are rarely binary, often subtle, reflecting small changes
in sensitivity, and can involve shifts in synchrony as much as
quantitative shifts of expression. We need to invest research into a
better understanding of such systems, using computer modelling
and systems approaches in addition to discovery in order to
extend our frontiers.
PHYSIOLOGY IS MORE THAN
MOLECULES, E.G., UTERINE
PERISTALSIS
Molecular analysis has dominated recent decades of research
in reproduction and has the advantage of providing hard,
quantifiable data. It maps the molecular skeleton upon which
physiological forces can act. But it does not answer the
question of how things work. This deficit may explain in part
why reproduction as a clinical discipline is still reliant on
many surgical procedures as treatments, such as hysterectomy,
prostatectomy, or caesarean section.
A good example is provided by the topic of uterine peristalsis.
Like the gut, the uterus is also enclosed within sequential layers
of longitudinal and circular smooth muscle and is subject to
directed peristaltic waves of contraction. At the most receptive
time of the menstrual or oestrous cycle, these contractions are
mostly in the direction cervix to fundus (i.e., from bottom to
top) coinciding with the opening of the valve or isthmus between
the uterus and the oviduct on the ovarian side producing a
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fertile oocyte. This is the optimal time for intercourse, and a
bolus of ejaculated sperm will pass the cervix and be transported
by a peristaltic wave to the open isthmus and to the oviduct
for fertilisation (Kunz and Leyendecker, 2002; Kuijsters et al.,
2017). Pituitary oxytocin and uterine oxytocin receptors may
also be involved in this contractility (Kunz et al., 2007). Later
in the cycle, the directionality of uterine peristalsis reverses;
the isthmus to the oviduct is closed and contractions serve to
flush out menstrual fluid through the cervix. It is believed that
the condition, endometriosis, whereby endometrial tissue grows
ectopically on peritoneal membranes or on the ovarian surface,
may be initiated by a dysperistalsis causing menstrual debris
including endometrial stem cells to be flushed in the wrong
direction through the oviduct and into the peritoneal cavity
(Child and Tan, 2001). Similarly, uterosalpingography, and more
recently cine-MRI, have shown that in infertile women, instead
of normal cervix-to-fundal peristalsis at ovulation, the waves are
reversed or irregular, thereby preventing sperm from fertilising
the egg. Moreover, it is believed that the presence of fibroids
is also a key factor in disrupting uterine peristalsis (Pier and
Bates, 2015). Furthermore, in some species, producing multiple
embryos, regular, standing peristaltic waves may be responsible
for spacing of the embryos within the uterus.
We know very little about how uterine peristalsis is controlled.
In analogy to the gut, it appears that there may be resident Cajal-
like cells, or telocytes, in the uterus, which acting as pacemakers
could coordinate myometrial contractility, in conjunction with
the autonomic nervous system (Hutchings et al., 2009; Banciu
et al., 2016). There does not appear to be any steroid-
induced geographic expression of oxytocin or other receptors.
Considering how important the observations described above
may be in relation to some of the major diseases affecting human
reproduction, endometriosis, fibroids, and/or infertility, as well
as conditions such as premature labour, it is perhaps surprising
that so little is known about this classical aspect of physiology.
But then this is not an aspect which can be easily assessed using
modern molecular techniques. New developments in cine-MRI
are making the assessment of uterine peristalsis more accessible,
though this is still some way from understanding causality or
identifying possible treatments.
At a cellular level, it has recently been shown for the rat uterus,
by combining electrophysiology using microelectrode arrays and
microanatomy, that contractility in late gestation appears to be
initiated by a “pacemaker” domain anatomically defined as a
specialist region of the myometrium adjacent to placental tissue
(Lutton et al., 2018). How such domains function and whether the
concept applies to other times besides late gestation, or in other
species, remains to be clarified.
BIODIVERSITY, BEHAVIOUR, AND THE
BIGGER PICTURE
The loss of biodiversity and loss of endangered species are also
aspects touching the physiology of reproduction. This may be
direct in that the reproductive system of a particular species
is suffering dysfunction through exposure to environmental
chemicals, or genetic inbreeding and an environment to which
the species is not well adapted. Or it may be indirect because
the behavioural context for appropriate reproductive physiology
is dysfunctional. For example, it has been shown that EDC
exposure can upset mating behaviour in rats without having any
other obvious molecular or physiological consequences. Without
going into detail, it is important to note that only when an
integrated physiological approach is taken, which considers all
aspects pertaining to reproduction (genetics, behaviour, ecology,
endocrinology, and reproductive physiology) will it be possible to
understand and thus develop solutions to the current biodiversity
problem. While modern approaches to develop ART procedures
suitable for endangered species, such as rhinoceros, are essential
and laudable, only when these can be integrated into the larger
physiological and environmental context of habitat renewal and
behavioural monitoring, can any success be expected. Thus, the
importance of taking a physiological approach in reproductive
science is that it – by definition – is integrative and inclusive of
a wide range of methodologies, rather than being constricted by
a discipline-based focus on the molecular or the genetic.
LIGHT ON THE HORIZON—NEW
METHODS AND APPROACHES
As outlined above, the static cell-molecule approach needs
to transmute into a more dynamic and integrated systems
methodology. The progression of stem cell biology and the
development of lineage into more complex in vitro models
using organoids are already providing important dynamic
information about cell–cell interactions. Similarly, the evolution
of microfluidics systems allowing informational integration
between different organ components is beginning to illuminate
the reciprocal dynamics of the oestrous cycle (Xiao et al.,
2017). Combining multiple single-cell transcriptomics across
tissue sections is highlighting the dynamic heterogeneity of the
endometrium and the placental–maternal interface, besides for
the first time functionally identifying the roles of individual
cells in their natural context (Vento-Tormo et al., 2018;
Garcia-Alonso et al., 2021). This new methodology, like the
myometrial electrophysiology mentioned earlier, has in common
that instead of homogenising tissue expression data, as in
the past, it is celebrating the heterogeneity of single cells
and their functionality, and combined with a systems biology
computational approach, is allowing us for the first time
to appreciate the spatial and temporal dynamics essential to
reproductive function.
On a larger scale, mid-gestational foetal-maternal
development has always represented a relatively inaccessible
“black box,” whose disruption is considered critical in terms of
maternal and foetal pathology (pre-term labour, preeclampsia,
gestational diabetes, miscarriage, foetal organogenesis, and
DOHaD). Access to placental, foetal, and amniotic samples
for analysis, and also non-invasive methods are very limited.
However, the recent breakthrough development of an artificial
placenta and/or artificial womb is providing hope not only for
the survival of ever-earlier pre-term infants, but also in terms of
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our understanding of the dynamic foetal–maternal interchange
(De Bie et al., 2020).
CONCLUDING REMARKS
This essay makes no attempt to be comprehensive or present a
balanced summary of current research into reproductive science.
Numerous excellent recent clinical and molecular advances have
been ignored. Rather it attempts to show how our current focus
on molecular detail may be obscuring our understanding of the
mechanisms and processes which govern the functioning of our
reproductive organs and tissues. These are highly dynamic and
require a different kind of approach which is integrative in both
space and time. Such new approaches will also probably require
different statistical and computational methodologies, besides
new techniques and new models. We have learnt to dissect and
take apart the system into its component molecules, now it is time
to put this knowledge back together again and understand how
the complete system works.
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